A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma. - Wikidata - awgldk - TriplyDB

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

http://www.wikidata.org/entity/Q35752244

about

Regulation of TAZ in cancer Prognostic significance of TAZ expression in various cancers: a meta-analysis A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells.Expression of YAP/TAZ in Keratocystic Odontogenic Tumors and Its Possible Association with Proliferative Behavior.Transcriptional co-activator with PDZ-binding motif overexpression promotes cell proliferation and transcriptional co-activator with PDZ-binding motif deficiency induces cell cycle arrest in neuroblastoma.ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.High expression of TAZ indicates a poor prognosis in retinoblastoma.The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.YAP/TAZ at the Roots of Cancer.Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis.Clinical significance of YAP1 activation in head and neck squamous cell carcinoma.Targeting oral cancer epigenome via LSD1.Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond.YAP/TAZ Activation as a Target for Treating Metastatic Cancer.Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer YAP drives cutaneous squamous cell carcinoma formation and progression Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma

P2860

Q26740462-8AF82F95-47C4-497F-8AFE-1B8263D17093 Q28078348-BBD20884-822B-42C3-A688-6B8151EB91FE Q30843628-55FC38F1-6CF4-44D9-A22F-FDA2A8F71153 Q33645455-76D49BA0-DCC4-4CEE-8CD2-7260D27D408E Q33751099-FAB3481D-280E-41B6-BE95-3E1919C62F01 Q34548405-E4BF9727-4020-4AAD-B98A-453F7827C806 Q36160368-E96763B5-55DB-4D00-9D57-DA6BED1629FA Q36286883-11194810-88DC-4BDA-9891-257967ADEAFE Q36690990-9E776197-D27F-4168-A260-80D380E228A7 Q36923438-166B18E4-AC1E-49B7-94F1-A4E1B3828858 Q37239849-06DD7EA4-1218-4C18-A7C7-68C406BAB0DD Q37697120-CC6F67BB-9265-4312-A169-825BB2DC9523 Q38514410-30927D17-3E8D-4173-90D2-27C0B5F6E570 Q38864941-A9E9FBA6-9848-4802-B4CA-BAE06A3A7D57 Q47582238-493DC36E-64F7-450B-887F-6335CC2F8A0B Q47860989-C532BBA3-66CC-4E13-9E0E-E88269FBBD52 Q49792796-214AB917-A759-47EC-9E1A-6715F955846E Q50131782-5CFE64E5-BA2E-4F2B-8D78-21AFC23E9902 Q54977387-44AA8DC9-B0F3-4F7C-9FDD-1D097A250A50 Q58197289-F3FDB9F8-DEC4-4506-B10A-9A83B7469A98 Q58292739-F5945E24-652C-470A-B020-B8FF2547684C Q58791810-9CF42D62-E463-48A6-B77D-4723E5F452EE Q59127492-10878FAD-2D4F-4623-BE8B-A218B22E25A9

P2860

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

http://www.wikidata.org/entity/Q35752244

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@ast

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@en

type

label

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@ast

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@en

prefLabel

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@ast

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@en

P1433

Q35752244-27093406-6DC1-48BE-989F-1E680AC99D68

P1476

Q35752244-F3CCF948-F58E-41B2-B7E3-02E9CEE48A6D

P2093

Q35752244-0326AB53-2A02-45DF-9539-8B67701D1FC4

Q35752244-9EBF9CE9-0433-4FAC-AA27-8E5FB08702A5

Q35752244-AE13941C-9950-4F07-B1F7-C84E2AA15CA9

Q35752244-BCC2A82D-C539-49B5-AF4F-FCBB528F6A7F

Q35752244-FB47231A-E13E-4510-BF51-8F2E67B782D0

P2860

Q35752244-08ADEF7E-B8F0-4FE6-8FF1-B98961D739F1

Q35752244-14307A06-0207-4A5D-963F-BA9BC8B35240

Q35752244-1B26AF9C-8C12-4BB2-BD0E-149EDECBB2B5

Q35752244-1E5383E3-8439-4734-8918-D5EF1317490E

Q35752244-1F2F8D53-AF14-4B95-ABD2-3A364EF24386

Q35752244-21186514-D216-48E5-911A-430A223B853A

Q35752244-222F12CD-6E05-475A-BD85-28ED6722C2CC

Q35752244-2386E823-9146-4BE3-AF64-CDE26FC2EA80

Q35752244-34FBC2A9-0E15-45AF-9C7C-BDD9C1D83206

Q35752244-3C7ADDBC-16D9-433F-BFDF-FB869F9ECEF9

P304

Q35752244-572BD3A1-AA15-4101-BB4D-C503773B1E6F

P31

Q35752244-3F819FFC-815C-4339-AC8C-B58565E33BDB

P356

Q35752244-206BBFB3-8416-4AE9-9BD3-CBB3FC8731B3

P433

Q35752244-1F912175-DDAA-4383-B448-820E7839388A

P478

Q35752244-3C872833-940E-449D-A4D5-D115104555BB

P50

Q35752244-2839BFA9-D78E-449B-A0AD-EC87D9B9A494

Q35752244-48EE827E-8D4A-4303-AC1B-72357F012C0C

Q35752244-C8F8CA1B-CC97-4282-80B6-A767E6568A09

Q35752244-D887A27F-A6D1-4F69-A9BA-A0AE456C53CD

Q35752244-FEAE2FBE-4AB5-4A6A-ADF0-F98960BC136C

P577

Q35752244-D35D3CA1-2640-4FA4-BA9A-6891D13C06D5

P698

Q35752244-81BE467A-E927-435F-98C1-7D8DFB219608

P932

Q35752244-4ECB39D4-F80C-4E8C-A52A-57FF47FAFC1A

P356

1541-7786.MCR-14-0580

P1433

Molecular Cancer Research

P1476

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

@en

P2093

Liye Zhang

http://www.w3.org/2001/XMLSchema#string

Maria Kukuruzinska

http://www.w3.org/2001/XMLSchema#string

Munirah Almershed

http://www.w3.org/2001/XMLSchema#string

Samantha E Hiemer

http://www.w3.org/2001/XMLSchema#string

Trevor S Packer

http://www.w3.org/2001/XMLSchema#string

P2860

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)

Yap1 acts downstream of α-catenin to control epidermal proliferation

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

The Hippo pathway regulates Wnt/beta-catenin signaling

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

TEAD mediates YAP-dependent gene induction and growth control

Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer

P304

957-968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-14-0580

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Xaralabos Varelas

P577

2015-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25794680

http://www.w3.org/2001/XMLSchema#string

P932

4470857

http://www.w3.org/2001/XMLSchema#string